Vicarious Surgical (RBOT) Non Operating Investment Income (2021 - 2025)
Vicarious Surgical (RBOT) posted quarterly Non Operating Investment Income of -$18000.0 for Q2 2025, down 80.0% year-over-year from -$90000.0 in Q2 2024, and up 43.75% quarter-over-quarter from -$32000.0 in Q1 2025.
Vicarious Surgical (RBOT) Non Operating Investment Income (2021 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Non Operating Investment Income for 4 consecutive years, with -$18000.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Non Operating Investment Income fell 80.0% year-over-year to -$18000.0; the TTM figure through Jun 2025 stood at $51000.0 (down 35.44% YoY), while the FY2024 annual figure was $40000.0, up 300.0% from the prior year.
- Non Operating Investment Income advanced to -$18000.0 in Q2 2025 per RBOT's latest filing, from -$32000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $175000.0 in Q3 2024 and bottomed at -$195000.0 in Q2 2023.
- Historically, Non Operating Investment Income has averaged $6187.0 across 4 years, with a median of -$1513.5 in 2021.
- On a YoY basis, Non Operating Investment Income climbed as much as 326.83% in 2024 and fell as far as 178.46% in 2024.
- Vicarious Surgical's Non Operating Investment Income stood at $6973.0 in 2021, then surged by 1319.76% to $99000.0 in 2023, then slumped by 174.75% to -$74000.0 in 2024, then jumped by 75.68% to -$18000.0 in 2025.
- Business Quant data shows RBOT's Non Operating Investment Income at -$18000.0 in Q2 2025, -$32000.0 in Q1 2025, and -$74000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Vicarious Surgical | 208,404.18 | -14.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -18,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -51,000.00 |
| Mar 31, 2024 | -51,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -195,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Mar 31, 2023 | 65,000.00 |